|
Volumn 432, Issue 3, 1998, Pages 155-157
|
CD95-mediated apoptosis: No variation in cellular sensitivity during cell cycle progression
|
Author keywords
Apoptosis; CD95; Cell cycle
|
Indexed keywords
APHIDICOLIN;
CAMPTOTHECIN;
CISPLATIN;
DEFEROXAMINE;
DOXORUBICIN;
FAS ANTIGEN;
HYDROXYUREA;
MIMOSINE;
NIMUSTINE;
NOCODAZOLE;
PACLITAXEL;
PROTEIN P53;
TENIPOSIDE;
VINCRISTINE;
ANTIGEN EXPRESSION;
APOPTOSIS;
ARTICLE;
CANCER CELL;
CELL CYCLE;
CONTROLLED STUDY;
GLIOMA CELL;
HELA CELL;
HEPATOMA CELL;
HUMAN;
HUMAN CELL;
LEUKEMIA CELL LINE;
PRIORITY JOURNAL;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTIGENS, CD95;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
APHIDICOLIN;
APOPTOSIS;
CAMPTOTHECIN;
CELL CYCLE;
CELL DEATH;
CISPLATIN;
CULTURE MEDIA, SERUM-FREE;
DOXORUBICIN;
ENZYME INHIBITORS;
FAS LIGAND PROTEIN;
GENE EXPRESSION;
HELA CELLS;
HUMANS;
HYDROXYUREA;
JURKAT CELLS;
MEMBRANE GLYCOPROTEINS;
NIMUSTINE;
NOCODAZOLE;
PACLITAXEL;
SENSITIVITY AND SPECIFICITY;
TENIPOSIDE;
TUMOR CELLS, CULTURED;
VINCRISTINE;
|
EID: 0031709344
PISSN: 00145793
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-5793(98)00855-2 Document Type: Article |
Times cited : (11)
|
References (8)
|